NasdaqGM - Nasdaq Real Time Price USD

NeuroPace, Inc. (NPCE)

Compare
10.56
-1.11
(-9.51%)
As of 3:47:29 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
79,906
79,906
65,421
45,520
45,183
Cost of Revenue
20,821
20,821
17,299
13,027
11,748
Gross Profit
59,085
59,085
48,122
32,493
33,435
Operating Expense
80,756
80,756
75,296
73,287
57,172
Operating Income
-21,671
-21,671
-27,174
-40,794
-23,737
Net Non Operating Interest Income Expense
-5,774
-5,774
-5,467
-5,951
-6,962
Other Income Expense
304
304
-315
-337
-5,381
Pretax Income
-27,141
-27,141
-32,956
-47,082
-36,080
Net Income Common Stockholders
-27,141
-27,141
-32,956
-47,082
-36,080
Diluted NI Available to Com Stockholders
-27,141
-27,141
-32,956
-47,082
-36,080
Basic EPS
-0.93
--
-1.27
-1.91
-2.17
Diluted EPS
-0.93
--
-1.27
-1.91
-2.17
Basic Average Shares
29,126.31
--
25,851.81
24,594.78
16,608.80
Diluted Average Shares
29,126.31
--
25,851.81
24,594.78
16,608.80
Total Operating Income as Reported
-21,671
-21,671
-27,174
-40,794
-23,737
Total Expenses
101,577
101,577
92,595
86,314
68,920
Net Income from Continuing & Discontinued Operation
-27,141
-27,141
-32,956
-47,082
-36,080
Normalized Income
-27,141
-27,141
-32,956
-47,082
-36,080
Interest Income
3,024
3,024
3,050
1,578
448
Interest Expense
8,798
8,798
8,517
7,529
7,410
Net Interest Income
-5,774
-5,774
-5,467
-5,951
-6,962
EBIT
-18,343
-18,343
-24,439
-39,553
-28,670
EBITDA
-16,574
-16,574
-22,834
-36,566
-28,374
Reconciled Cost of Revenue
20,821
20,821
17,299
13,027
11,748
Reconciled Depreciation
1,769
1,769
1,605
2,987
296
Net Income from Continuing Operation Net Minority Interest
-27,141
-27,141
-32,956
-47,082
-36,080
Normalized EBITDA
-16,574
-16,574
-22,834
-36,566
-28,374
12/31/2021 - 4/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CBLL CeriBell, Inc.
10.43
-45.53%
 
TMCI Treace Medical Concepts, Inc.
6.98
-5.87%
 
CVRX CVRx, Inc.
6.53
-10.25%
 
KIDS OrthoPediatrics Corp.
21.32
-7.43%
 
SGHT Sight Sciences, Inc.
2.2600
-3.83%
 
LIVN LivaNova PLC
34.09
-4.56%
 
OSSD.ST OssDsign AB (publ)
13.22
+9.26%
 
BBNX Beta Bionics, Inc.
10.45
-11.52%
 
BVS Bioventus Inc.
7.54
-5.22%
 
TELA TELA Bio, Inc.
0.9300
-9.69%